Found: 23
Select item for more details and to access through your institution.
Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review.
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 2, p. 433, doi. 10.1007/s10555-022-10023-9
- By:
- Publication type:
- Article
FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 145, doi. 10.1007/s10549-020-05929-3
- By:
- Publication type:
- Article
2-[<sup>18</sup>F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32727-w
- By:
- Publication type:
- Article
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4080, doi. 10.3390/cancers13164080
- By:
- Publication type:
- Article
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1190, doi. 10.3390/cancers11081190
- By:
- Publication type:
- Article
Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00833-3
- By:
- Publication type:
- Article
Perspective of Patients with Metastatic Breast Cancer on Electronic Access to Scan Results: Mixed-Methods Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 12, p. 2211, doi. 10.1002/ijc.35126
- By:
- Publication type:
- Article
Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing <sup>18</sup>F-FDG PET/CT with Conventional CT.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 355, doi. 10.2967/jnumed.121.263358
- By:
- Publication type:
- Article
Response monitoring in metastatic breast cancer – a prospective study comparing <sup>18</sup>F-FDG PET/CT with conventional CT.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263358
- By:
- Publication type:
- Article
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.
- Published in:
- 2022
- By:
- Publication type:
- journal article
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 4, p. 723, doi. 10.3390/diagnostics11040723
- By:
- Publication type:
- Article
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1001, doi. 10.3390/diagnostics10121001
- By:
- Publication type:
- Article
Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 6, p. 398, doi. 10.3390/diagnostics10060398
- By:
- Publication type:
- Article
FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review.
- Published in:
- Diagnostics (2075-4418), 2019, v. 9, n. 3, p. 106, doi. 10.3390/diagnostics9030106
- By:
- Publication type:
- Article
Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 11, p. 1362, doi. 10.1080/0284186X.2022.2137844
- By:
- Publication type:
- Article
Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 7, p. 741, doi. 10.1080/0284186X.2020.1757148
- By:
- Publication type:
- Article
The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [ 18 F]FDG-PET/CT and CE-CT.
- Published in:
- Journal of Imaging, 2023, v. 9, n. 10, p. 222, doi. 10.3390/jimaging9100222
- By:
- Publication type:
- Article
Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer.
- Published in:
- Journal of Imaging, 2023, v. 9, n. 3, p. 1, doi. 10.3390/jimaging9030065
- By:
- Publication type:
- Article
Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer.
- Published in:
- Research Involvement & Engagement, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40900-019-0174-y
- By:
- Publication type:
- Article
Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43446-7
- By:
- Publication type:
- Article
Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43446-7
- By:
- Publication type:
- Article
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 5, p. 1, doi. 10.1007/s12032-024-02356-y
- By:
- Publication type:
- Article